MILESTONE PHARMACEUTICALS IN's ticker is MIST and the CUSIP is 59935V107. A total of 31 filers reported holding MILESTONE PHARMACEUTICALS IN in Q2 2021. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $54,485 | +8.8% | 17,576 | 0.0% | 0.00% | – |
| Q2 2023 | $50,091 | -27.7% | 17,576 | 0.0% | 0.00% | – |
| Q1 2023 | $69,249 | +100260.9% | 17,576 | 0.0% | 0.00% | – |
| Q4 2022 | $69 | -100.0% | 17,576 | 0.0% | 0.00% | – |
| Q3 2022 | $161,000 | +54.8% | 17,576 | 0.0% | 0.00% | – |
| Q2 2022 | $104,000 | -7.1% | 17,576 | 0.0% | 0.00% | – |
| Q1 2022 | $112,000 | -2.6% | 17,576 | 0.0% | 0.00% | – |
| Q4 2021 | $115,000 | +15.0% | 17,576 | 0.0% | 0.00% | – |
| Q3 2021 | $100,000 | -12.3% | 17,576 | -15.7% | 0.00% | – |
| Q2 2021 | $114,000 | -5.0% | 20,859 | 0.0% | 0.00% | – |
| Q1 2021 | $120,000 | -4.8% | 20,859 | +10.1% | 0.00% | – |
| Q4 2020 | $126,000 | +35.5% | 18,945 | +48.1% | 0.00% | – |
| Q3 2020 | $93,000 | +93.8% | 12,795 | 0.0% | 0.00% | – |
| Q2 2020 | $48,000 | – | 12,795 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 1,750,043 | $11,464,000 | 1.71% |
| Novo Holdings A/S | 2,530,585 | $16,575,000 | 0.78% |
| Boxer Capital, LLC | 2,238,861 | $14,665,000 | 0.57% |
| RTW INVESTMENTS, LP | 4,315,102 | $28,264,000 | 0.41% |
| RA Capital Management | 2,246,503 | $14,715,000 | 0.26% |
| Bleichroeder LP | 250,000 | $1,638,000 | 0.26% |
| PURA VIDA INVESTMENTS, LLC | 931,511 | $6,101,000 | 0.22% |
| Orbimed Advisors | 2,583,821 | $16,924,000 | 0.22% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 851,291 | $5,576,000 | 0.11% |
| Eversept Partners, LP | 147,165 | $963,931 | 0.06% |